Frederic Pont
Overview
Explore the profile of Frederic Pont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
979
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pont F, Tosolini M, Gao Q, Perrier M, Madrid-Mencia M, Huang T, et al.
NAR Genom Bioinform
. 2021 Feb;
2(2):lqaa025.
PMID: 33575582
The development of single-cell transcriptomic technologies yields large datasets comprising multimodal informations, such as transcriptomes and immunophenotypes. Despite the current explosion of methods for pre-processing and integrating multimodal single-cell data,...
12.
Guerby P, Tasta O, Swiader A, Pont F, Bujold E, Parant O, et al.
Redox Biol
. 2021 Feb;
40:101861.
PMID: 33548859
Preeclampsia (PE) is a multifactorial pregnancy disease, characterized by new-onset gestational hypertension with (or without) proteinuria or end-organ failure, exclusively observed in humans. It is a leading cause of maternal...
13.
Balanca C, Salvioni A, Scarlata C, Michelas M, Martinez-Gomez C, Gomez-Roca C, et al.
JCI Insight
. 2020 Dec;
6(2).
PMID: 33332284
Tumor antigen-specific CD4 T cells accumulate at tumor sites, evoking their involvement in antitumor effector functions in situ. Contrary to CD8 cytotoxic T lymphocyte exhaustion, that of CD4 T cells...
14.
Cadot S, Valle C, Tosolini M, Pont F, Largeaud L, Laurent C, et al.
Biomark Res
. 2020 Dec;
8(1):72.
PMID: 33298182
Background: Ibrutinib, an irreversible Bruton Tyrosine Kinase (BTK) inhibitor, has revolutionized Chronic Lymphocytic Leukemia (CLL) treatment, but resistances to ibrutinib have emerged, whether related or not to BTK mutations. Patterns...
15.
Balanca C, Scarlata C, Michelas M, Devaud C, Sarradin V, Franchet C, et al.
Cancer Immunol Res
. 2020 Apr;
8(7):869-882.
PMID: 32295784
Although understanding of T-cell exhaustion is widely based on mouse models, its analysis in patients with cancer could provide clues indicating tumor sensitivity to immune checkpoint blockade (ICB). Data suggest...
16.
Tata S, Aouiche A, Bijani C, Bouras N, Pont F, Mathieu F, et al.
Saudi Pharm J
. 2020 Jan;
27(7):907-913.
PMID: 31997896
In our previous studies, the production of four bioactive molecules by sp. PAL114 in complex ISP2 broth medium has been described. Three of these molecules belong to the angucycline family....
17.
Guerby P, Swiader A, Tasta O, Pont F, Rodriguez F, Parant O, et al.
Free Radic Biol Med
. 2019 Jul;
141:416-425.
PMID: 31323312
Preeclampsia (PE) is a leading cause of pregnancy complications, affecting 3-7% of pregnant women worldwide. The pathophysiology of preeclampsia involves a redox imbalance, oxidative stress and a reduced nitric oxide...
18.
Pont F, Tosolini M, Fournie J
Nucleic Acids Res
. 2019 Jul;
47(21):e133.
PMID: 31294801
The momentum of scRNA-seq datasets prompts for simple and powerful tools exploring their meaningful signatures. Here we present Single-Cell_Signature_Explorer (https://sites.google.com/site/fredsoftwares/products/single-cell-signature-explorer), the first method for qualitative and high-throughput scoring of any...
19.
Pizzolato G, Kaminski H, Tosolini M, Franchini D, Pont F, Martins F, et al.
Proc Natl Acad Sci U S A
. 2019 May;
116(24):11906-11915.
PMID: 31118283
γδ T lymphocytes represent ∼1% of human peripheral blood mononuclear cells and even more cells in most tissues of vertebrates. Although they have important anticancer functions, most current single-cell RNA...
20.
Perchey R, Tonini L, Tosolini M, Fournie J, Lopez F, Besson A, et al.
Sci Rep
. 2019 Mar;
9(1):4181.
PMID: 30862887
Discovery of protein modification sites relies on protein digestion by proteases and mass spectrometry (MS) identification of the modified peptides. Depending on proteases used and target protein sequence, this method...